These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9615586)

  • 1. [Attention deficit/hyperactivity (AD/HD)--development of terminology].
    Lindback T
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1572-4. PubMed ID: 9615586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
    Rader R; McCauley L; Callen EC
    Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
    Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAMP and MBD versus AD/HD and hyperkinetic disorders.
    Rydelius PA
    Acta Paediatr; 2000 Mar; 89(3):266-8. PubMed ID: 10772271
    [No Abstract]   [Full Text] [Related]  

  • 6. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG coherence in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Barry RJ; Clarke AR; McCarthy R; Selikowitz M
    Clin Neurophysiol; 2007 Feb; 118(2):356-62. PubMed ID: 17140845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperkinetic disorders--AD/HD, MBD/DAMP--how are we supposed to name it?].
    Hundevadt L
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1600-1. PubMed ID: 9615592
    [No Abstract]   [Full Text] [Related]  

  • 10. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the diagnostic utility of EEG power measures in children with attention deficit/hyperactivity disorder.
    Magee CA; Clarke AR; Barry RJ; McCarthy R; Selikowitz M
    Clin Neurophysiol; 2005 May; 116(5):1033-40. PubMed ID: 15826843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D4 receptor gene and attention deficit hyperactivity disorder.
    Frank Y; Pergolizzi RG; Perilla MJ
    Pediatr Neurol; 2004 Nov; 31(5):345-8. PubMed ID: 15519116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and gender effects in EEG coherence: III. Girls with attention-deficit/hyperactivity disorder.
    Barry RJ; Clarke AR; McCarthy R; Selikowitz M
    Clin Neurophysiol; 2006 Feb; 117(2):243-51. PubMed ID: 16376608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention deficit/hyperactivity. Diagnostic criteria and classification].
    Sanne B; Lie N; Medhus M
    Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2949-52. PubMed ID: 9340853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-IV AD/HD: confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children.
    Gomez R; Harvey J; Quick C; Scharer I; Harris G
    J Child Psychol Psychiatry; 1999 Feb; 40(2):265-74. PubMed ID: 10188709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
    Ghanizadeh A
    J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a standard psychiatric evaluation to rating scales and EEG in the differential diagnosis of attention-deficit/hyperactivity disorder.
    Quintana H; Snyder SM; Purnell W; Aponte C; Sita J
    Psychiatry Res; 2007 Aug; 152(2-3):211-22. PubMed ID: 17451810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sluggish cognitive tempo: symptoms of predominantly inattentive attention deficit hyperactivity disorder or a new clinical entity?].
    Capdevila-Brophy C; Artigas-Pallarés J; Obiols-Llandrich JE
    Rev Neurol; 2006 Feb; 42 Suppl 2():S127-34. PubMed ID: 16555205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and ERP indices of response inhibition during a Stop-signal task in children with two subtypes of Attention-Deficit Hyperactivity Disorder.
    Johnstone SJ; Barry RJ; Clarke AR
    Int J Psychophysiol; 2007 Oct; 66(1):37-47. PubMed ID: 17604142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.